These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28744845)

  • 41. Pharmacovigilance in ophthalmology in Switzerland: an analysis of the most frequently reported ocular adverse drug reactions within the last 25 years.
    Karrer JE; Giovannoni L; Kullak-Ublick GA; Weiler S
    Swiss Med Wkly; 2019 Jun; 149():w20085. PubMed ID: 31256417
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Quantitative Analysis of FDA Adverse Event Reports with Oral Bisphosphonates and Clostridium difficile.
    McConeghy KW; Soriano MM; Danziger LH
    Pharmacotherapy; 2016 Oct; 36(10):1095-1101. PubMed ID: 27582058
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk of diabetes with fibrates and statins: a pharmacoepidemiological study in VigiBase
    Montastruc F; Benevent J; Rousseau V; Durrieu G; Sommet A; Montastruc JL
    Fundam Clin Pharmacol; 2019 Feb; 33(1):108-112. PubMed ID: 30098074
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adverse drug reactions of botulinum neurotoxin type A in children with cerebral palsy: a pharmaco-epidemiological study in VigiBase.
    Montastruc J; Marque P; Moulis F; Bourg V; Lambert V; Durrieu G; Montastruc JL; Montastruc F
    Dev Med Child Neurol; 2017 Mar; 59(3):329-334. PubMed ID: 27682175
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immune checkpoint inhibitor-associated thyroid dysfunction: a disproportionality analysis using the WHO Adverse Drug Reaction Database, VigiBase.
    Bai X; Chen X; Wu X; Huang Y; Zhuang Y; Lin X
    Eur J Endocrinol; 2020 Jan; 182(1):1-9. PubMed ID: 31648184
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of disproportionality analysis methods in national adverse drug reaction databases of China.
    Hou Y; Ye X; Wu G; Cheng G; Du X; He J
    Expert Opin Drug Saf; 2014 Jul; 13(7):853-7. PubMed ID: 24918197
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Seizure risk associated with neuroactive drugs: data from the WHO adverse drug reactions database.
    Kumlien E; Lundberg PO
    Seizure; 2010 Mar; 19(2):69-73. PubMed ID: 20036167
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Atropinic (anticholinergic) burden in antipsychotic-treated patients.
    Montastruc F; Benevent J; Touafchia A; Chebane L; Araujo M; Guitton-Bondon E; Durrieu G; Arbus C; Schmitt L; Begaud B; Montastruc JL
    Fundam Clin Pharmacol; 2018 Feb; 32(1):114-119. PubMed ID: 28887902
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System.
    Antonazzo IC; Raschi E; Forcesi E; Riise T; Bjornevik K; Baldin E; De Ponti F; Poluzzi E
    Expert Opin Drug Saf; 2018 Sep; 17(9):869-874. PubMed ID: 30058390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The value of time-to-onset in statistical signal detection of adverse drug reactions: a comparison with disproportionality analysis in spontaneous reports from the Netherlands.
    Scholl JH; van Puijenbroek EP
    Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1361-1367. PubMed ID: 27686554
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of Substandard Medicines via Disproportionality Analysis of Individual Case Safety Reports.
    Trippe ZA; Brendani B; Meier C; Lewis D
    Drug Saf; 2017 Apr; 40(4):293-303. PubMed ID: 28130773
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of cellular targets involved in cardiac failure caused by PKI in oncology: an approach combining pharmacovigilance and pharmacodynamics.
    Patras de Campaigno E; Bondon-Guitton E; Laurent G; Montastruc F; Montastruc JL; Lapeyre-Mestre M; Despas F
    Br J Clin Pharmacol; 2017 Jul; 83(7):1544-1555. PubMed ID: 28098949
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative study of hypoglycaemia induced by opioids. Is it a class effect?
    Chrétien B; Dolladille C; Hamel-Sénécal L; Sassier M; Faillie JL; Miremont-Salamé G; Lelong-Boulouard V; Le Boisselier R; Fedrizzi S; Alexandre J; Humbert X
    Expert Opin Drug Saf; 2019 Oct; 18(10):987-992. PubMed ID: 31317815
    [No Abstract]   [Full Text] [Related]  

  • 54. Drug-Induced Anaphylaxis in a Vietnamese Pharmacovigilance Database: Trends and Specific Signals from a Disproportionality Analysis.
    Nguyen KD; Nguyen HA; Vu DH; Le TT; Nguyen HA; Dang BV; Nguyen TN; Nguyen DH; Nguyen TB; Montastruc JL; Bagheri H
    Drug Saf; 2019 May; 42(5):671-682. PubMed ID: 30478823
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Possible occurrence of paraesthesia in patients taking norethisterone: an analysis on the WHO Global Individual Case Reports database (VigiBase).
    Buccellato E; Biagi C; Vaccheri A; Melis M; Montanaro N; Motola D
    Expert Opin Drug Saf; 2013 Sep; 12(5):615-9. PubMed ID: 23701188
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug-Induced Progressive Multifocal Leukoencephalopathy: A Comprehensive Analysis of the WHO Adverse Drug Reaction Database.
    Melis M; Biagi C; Småbrekke L; Nonino F; Buccellato E; Donati M; Vaccheri A; Motola D
    CNS Drugs; 2015; 29(10):879-91. PubMed ID: 26507833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Can drugs induce or aggravate sleep apneas? A case-noncase study in VigiBase
    Linselle M; Sommet A; Bondon-Guitton E; Moulis F; Durrieu G; Benevent J; Rousseau V; Chebane L; Bagheri H; Montastruc F; Montastruc JL
    Fundam Clin Pharmacol; 2017 Jun; 31(3):359-366. PubMed ID: 28036099
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disproportionality analysis in VigiBase as a drug repositioning method for the discovery of potentially useful drugs in Alzheimer's disease.
    Chrétien B; Jourdan JP; Davis A; Fedrizzi S; Bureau R; Sassier M; Rochais C; Alexandre J; Lelong-Boulouard V; Dolladille C; Dallemagne P
    Br J Clin Pharmacol; 2021 Jul; 87(7):2830-2837. PubMed ID: 33274491
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacovigilance Assessment of Drug-Induced Acute Pancreatitis Using a Spontaneous Reporting Database.
    Niinomi I; Hosohata K; Oyama S; Inada A; Wakabayashi T; Iwanaga K
    Int J Toxicol; 2019; 38(6):487-492. PubMed ID: 31470743
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibase.
    Edwards IR; Star K; Kiuru A
    Drug Saf; 2007; 30(6):515-25. PubMed ID: 17536877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.